EODData

LSE, 0WA2: Cellectis Ord Shs

20 May 2026
LAST:

3.197

CHANGE:
 0.07
OPEN:
3.230
HIGH:
3.230
ASK:
1.828
VOLUME:
3.9K
CHG(%):
2.02
PREV:
3.263
LOW:
3.150
BID:
1.740
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 May 263.2303.2303.1503.1973.9K
19 May 263.3383.3383.2633.263362
18 May 263.5683.5903.3393.3392.8K
15 May 263.5703.7043.5443.6205.6K
14 May 263.5643.7183.5583.57910.3K
13 May 263.3643.4913.3643.491619
12 May 263.2703.3963.2103.396366
11 May 263.3003.4283.1613.41015.8K
08 May 263.3103.2263.2023.189442
07 May 263.3563.4303.2303.2305.6K

PROFILE

Name:Cellectis Ord Shs
About:Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company was founded in 1999 and is headquartered in Paris, France.
Address:8, rue de la Croix Jarry, Paris, France, 75013
Website:https://www.cellectis.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-10.08 
PEG Ratio:0.10 
Price to Sales:12.05 
Price to Book:2.93 
Profit Margin:0.78 
Operating Margin:-3.20 
Return on Assets:-0.18 
Return on Equity:-0.63 
Revenue:21.01M 

TECHNICAL INDICATORS

MA5:3.406.3%
MA10:3.375.5%
MA20:3.354.8%
MA50:3.251.5%
MA100:3.365.0%
MA200:3.324.0%
STO9:1.51 
STO14:3.34 
RSI14:46.43
WPR14:-95.92 
MTM14:-0.10
ROC14:-0.03 
ATR:0.16 
Week High:3.7216.3%
Week Low:3.151.5%
Month High:3.7216.3%
Month Low:3.134.0%
Year High:4.8451.4%
Year Low:1.24157.8%
Volatility:59.25